Demirkol, D. Et Al. 2012. Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?. Critical care (London, England) , vol.16 .

Demirkol, D., YILDIZDAS, D., BAYRAKCI, B., KARAPINAR, B., KENDIRLI, T., KOROGLU, T., ... DURSUN, O.(2012). Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?. Critical care (London, England) , vol.16.

Demirkol, Demet Et Al. "Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?," Critical care (London, England) , vol.16, 2012

Demirkol, Demet Et Al. "Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?." Critical care (London, England) , vol.16, 2012

Demirkol, D. Et Al. (2012) . "Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?." Critical care (London, England) , vol.16.

@article{article, author={Demet DEMİRKOL Et Al. }, title={Hyperferritinemia in the critically ill child with secondary hemophagocytic lymphohistiocytosis/sepsis/multiple organ dysfunction syndrome/macrophage activation syndrome: what is the treatment?}, journal={Critical care (London, England)}, year=2012}